Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients
Clinical trial NCT02899299 · COMPLETED
Trial details
- NCT number
- NCT02899299
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-29
- Primary completion
- 2020-03-25
- Enrollment
- 605
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.